Matthew Leming, Ph.D., and Hyungsoon Im, Ph.D. of the Center for Systems Biology at Massachusetts General Hospital, are the ...

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular ...

High-resolution PET scanners and improved quantitative modeling methods are likely to increase our imaging specificity to test individual pathways, develop markers of activity or treatment ...

MRI imaging is used to help diagnose many conditions. It can provide images of structures in your body and help show areas of concern. If your doctor thinks you may have multiple sclerosis, an MRI ...

Multiple sclerosis (MS) is commonly regarded as an inflammatory disease, but it also has a neurodegenerative component, which represents an additional target for treatment. The use of MRI to ...

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and ...

Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS (na-SPMS) ...

A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs ...

Magnetic resonance imaging and other radiology tests have made it easier to diagnose and monitor multiple sclerosis. Learn what to expect from these tests.

Tropical Nights and Multiple Sclerosis Relapses: MRI Evidence —These findings suggest that multiple sclerosis has a seasonal variation of disease activity, with more activity in July and August ...

“Magnetic resonance imaging (MRI) biomarkers are vital for multiple sclerosis (MS) clinical research and trials but quantifying them requires multi-contrast protocols and limits the use of ...

Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS (na-SPMS) ...